Menu
GWAS Study

Genetic Architectures of Childhood- and Adult-Onset Asthma Are Partly Distinct.

Ferreira MAR, Mathur R, Vonk JM et al.

30929738 PubMed ID
GWAS Study Type
561282 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

FM
Ferreira MAR
MR
Mathur R
VJ
Vonk JM
SA
Szwajda A
BB
Brumpton B
GR
Granell R
BB
Brew BK
UV
Ullemar V
LY
Lu Y
JY
Jiang Y
MP
Magnusson PKE
KR
Karlsson R
HD
Hinds DA
PL
Paternoster L
KG
Koppelman GH
AC
Almqvist C
Chapter II

Abstract

Summary of the research findings

The extent to which genetic risk factors are shared between childhood-onset (COA) and adult-onset (AOA) asthma has not been estimated. On the basis of data from the UK Biobank study (n = 447,628), we found that the variance in disease liability explained by common variants is higher for COA (onset at ages between 0 and 19 years; h2g = 25.6%) than for AOA (onset at ages between 20 and 60 years; h2g = 10.6%). The genetic correlation (rg) between COA and AOA was 0.67. Variation in age of onset among COA-affected individuals had a low heritability (h2g = 5%), which we confirmed in independent studies and also among AOA-affected individuals. To identify subtype-specific genetic associations, we performed a genome-wide association study (GWAS) in the UK Biobank for COA (13,962 affected individuals) and a separate GWAS for AOA (26,582 affected individuals) by using a common set of 300,671 controls for both studies. We identified 123 independent associations for COA and 56 for AOA (37 overlapped); of these, 98 and 34, respectively, were reproducible in an independent study (n = 262,767). Collectively, 28 associations were not previously reported. For 96 COA-associated variants, including five variants that represent COA-specific risk factors, the risk allele was more common in COA- than in AOA-affected individuals. Conversely, we identified three variants that are stronger risk factors for AOA. Variants associated with obesity and smoking had a stronger contribution to the risk of AOA than to the risk of COA. Lastly, we identified 109 likely target genes of the associated variants, primarily on the basis of correlated expression quantitative trait loci (up to n = 31,684). GWAS informed by age of onset can identify subtype-specific risk variants, which can help us understand differences in pathophysiology between COA and AOA and so can be informative for drug development.

13,962 European ancestry cases, 300,671 European ancestry controls

Chapter III

Study Statistics

Key metrics and study information

561282
Total Participants
GWAS
Study Type
Yes
Replicated
31,759 European ancestry cases, 214,890 European ancestry controls
Replication Participants
European
Ancestry
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.